End-of-day quote
Other stock markets
|
||
- HKD | - |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Sales 2024 * | 3.08B 24.12B | Sales 2025 * | 3.92B 30.68B | Capitalization | 15.52B 122B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.98B | Net income 2025 * | -358M -2.8B | EV / Sales 2024 * | 4.56 x |
Net cash position 2024 * | 1.48B 11.6B | Net cash position 2025 * | 1.13B 8.85B | EV / Sales 2025 * | 3.67 x |
P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-40.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
+4.55% | 13.98B | |
+32.11% | 11.66B | |
-26.18% | 8.22B |